Cargando…
Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
Background. We performed prospective validation of the cancer ratio (serum LDH : pleural ADA ratio), previously reported as predictive of malignant effusion retrospectively, and assessed the effect of combining it with “pleural lymphocyte count” in diagnosing malignant pleural effusion (MPE). Method...
Autores principales: | Verma, Akash, Dagaonkar, Rucha S., Marshall, Dominic, Abisheganaden, John, Light, R. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192296/ https://www.ncbi.nlm.nih.gov/pubmed/28070157 http://dx.doi.org/10.1155/2016/7348239 |
Ejemplares similares
-
Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio)
por: Verma, Akash, et al.
Publicado: (2015) -
Age : pleural fluid ADA ratio and other indicators for differentiating between tubercular and malignant pleural effusions
por: Zhou, Jiupeng, et al.
Publicado: (2022) -
Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion
por: Gayaf, Mine, et al.
Publicado: (2021) -
Adenosine Deaminase (ADA) Level in Tubercular Pleural Effusion
por: Verma, S.K., et al.
Publicado: (2008) -
Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion
por: Hackner, Klaus, et al.
Publicado: (2019)